2m 2m 2m 2m 2m 2m 2m
INHIBIKASE THRP (IKT)
NASDAQ
$2.01+$0.005 (+0.25%)
Price as of Oct 02, 2026 7:30 PM EDT- $269.3MMarket Cap
- 20.48%1-Year Change
- BiotechnologyIndustry
INHIBIKASE THRP (IKT)
$2.01+$0.005 (+0.25%)
IKT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.00 | ||
Change | +$0.07 (+3.63%) | ||
Open | $1.96 | ||
High | $2.02 | ||
Low | $1.93 | ||
Previous Close | $1.93 | ||
Volume | 434,455 | ||
30-Day Average Volume | 560,409 | ||
1-Week Change | -2.91% | ||
1-Month Change | -20.00% | ||
1-Year Change | 20.48% | ||
3-Year Change | 44.93% | ||
5-Year Change | -82.82% | ||
Fundamentals | |||
Shares Outstanding | 139.5M | ||
Total Assets | $163.6M | ||
Market Cap | $269.3M | ||
Enterprise Value | $238.1M | ||
Period: QTR TTM FY | |||
Revenue | $1.5M | ||
Net Income | -$19.6M | ||
Free Cash Flow | -$12.4M | ||
EBIT | -$19.6M | ||
EBITDA | -$19.6M | ||
Net Working Capital | $152.1M | ||
EPS | -$0.11 | ||
Enterprise Value/EBITDA | -12 | ||
Enterprise Value/Revenue | 163 | ||
P/B | 2 | ||
P/E | -18 | ||
PEG | 2 | ||
Price/Free Cash Flow | -22 | ||
Price/Operating Cash Flow | -22 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 6 | ||
Last Split Date | 06/30/2023 | ||
Earnings & Revenue